Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-030069
Filing Date
2019-12-26
Accepted
2019-12-26 18:00:55
Documents
1
Period of Report
2019-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3984
  Complete submission text file 0000899243-19-030069.txt   5683
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Issuer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEKTAR THERAPEUTICS 150 INDUSTRIAL ROAD SAN CARLOS CA 94070
Business Address
Elam Nevan C (Reporting) CIK: 0001314773 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32157 | Film No.: 191311283